Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling (Q64714798)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling |
clinical trial |
Statements
Immunogenicity of a Commercial Batch of the Japanese Encephalitis Vaccine IC51 up to Twenty-four Months Post Filling. An Open-label, Multicenter, Phase 3 Study (English)
0 references
September 2008
0 references
June 2010
0 references
304
0 references
18 year
0 references